Skip to content

NUVB

Nuvation Bio Inc.

NYSE · Healthcare · Biotechnology · US

$4.73
+0.85%
Ask drillr

Forward multiples

Based on analyst estimates

P/E forward
—
P/E 2026E
—
P/E 2027E
—
P/E 2028E
—
P/S forward
7.08x

Trailing multiples

Trailing twelve months

P/E TTM
—
PEG TTM
—
Price / book
6.54x
Price / sales
9.78x
Price / cash flow
-13.78x

Enterprise value

Enterprise value
$1.3B
EV / sales
7.37x
EV / EBITDA
-9.86x
EV / EBIT
-9.10x
Market cap
$1.7B

Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026